Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04342767
Other study ID # EZ-1
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 19, 2020
Est. completion date June 16, 2020

Study information

Verified date March 2021
Source SerenaGroup, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This prospective clinical trial will compare the bacterial burden in the wound bed and on the periwound skin before and after mechanical debridement with EZ Debride using fluorescence imaging. After consenting, the ulcers of eligible subjects are measured, photographed and undergo the MolecuLight imaging procedure (MLiX). The ulcer is mechanically debridement with the EZ Debride device after which a second MLiX procedure is performed. The investigator will then compare the two images.


Description:

Acute and chronic wounds burden healthcare systems across the globe. In the United States the cost of nonhealing wounds approximates 100 billion dollars.1-3 The presence of bacteria in and around the wound impedes wound healing. Clinicians treat elevated wound bacterial levels with mechanical and sharp debridement, topical antiseptics and systemic antibiotics. However, evidence on the best methods to reduce bacterial load is lacking. The EZ-1 clinical trial will utilize the latest fluorescence imaging technology to investigate whether mechanical debridement using the EZ DebrideĀ® tool reduces bacterial burden.


Recruitment information / eligibility

Status Completed
Enrollment 28
Est. completion date June 16, 2020
Est. primary completion date June 16, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: 1. Adult patients with acute or chronic wounds that have been present for a minimum of 4 weeks. 2. A signed and dated informed consent form. 3. Subject is willing and able to comply with instructions and scheduled visits. Exclusion Criteria: 1. The Subject has other concurrent conditions that in the opinion of the Investigator may compromise subject safety. 2. The subject's wound has not been present for at least 4 weeks.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
EZ Debride®
EZ Debride ® is intended for the mechanical debridement of topical wounds including partial and full thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, surgical wounds (donor sites/grafts, post Mohs' surgery, post-laser surgery, podiatric, wound dehiscence) trauma wounds (abrasions, lacerations, second-degree burns and skin tears), draining wounds and tunnelled /undermined wounds.

Locations

Country Name City State
United States Serena Group Research Institute Pittsburgh Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
SerenaGroup, Inc. MDM Wound Ventures, LLC

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Bacterial Bioburden The reduction in bacterial bioburden following mechanical wound debridement as determined by the MolecuLight Procedure (MLiX). Before and After Mechanical debridement within 1 hour
Secondary Pain Score Pain scores (PEG) before, during and after mechanical debridement. Pain intensity of the reference ulcer is assessed before and after any wound cleansing using the PEG score
PEG Scale Assessing Pain Intensity and Interference (Pain, Enjoyment, General Activity). The PEG scale is a validated pain scoring system. It consists of three 1-10 rating scales: numerical, enjoyment of life and general activity. The subject indicates a numerical value that best represents the pain intensity at ulcer site on a scale of 0 to 10 anchored by word descriptors at each end, as "no pain" on the left side and "Pain as bad as you can imagine" on the right side of the number line. The number 0 represents "no pain", the number 5 represents "moderate pain" and the number 10 represents the "worst possible pain".
Before, during, and after mechanical debridement within 1 hour
Secondary Adverse Events Adverse events associated with mechanical debridement. During debridement
See also
  Status Clinical Trial Phase
Completed NCT01442103 - Clinical Utility of a New Silver Gel for Use on Chronic Wounds N/A
Completed NCT00425178 - FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers Phase 1
Not yet recruiting NCT04411264 - Evaluation of the Effect of Virtual Reality on Pain in the Management of Chronic Wounds. N/A
Recruiting NCT03882983 - Stromal Vascular Fraction From Lipoaspirate to Treatment of Chronic Non-healing Wound Phase 1
Completed NCT04903366 - Absorption and Safety of Topical Timolol to Treat Chronic Wounds
Not yet recruiting NCT05491291 - Chronic Wound Care of Lower Limb in M@diCICAT Center at CHU de Martinique N/A
Completed NCT01572376 - Autologous Bone Marrow Stem Cells in Pressure Ulcer Treatment Phase 1/Phase 2
Recruiting NCT06306716 - Single Center Clinical Study on New Negative Pressure Wound Therapy Dressing in the Management of Chronic & Acute Wounds
Completed NCT02053337 - A RCT to Compare Performance of Two Foam Dressings on Patient Well-being Related Endpoints. N/A
Completed NCT02519166 - Characterisation of Biofilm of the Chronic Wounds N/A
Completed NCT04320628 - Randomized Double-Blind Controlled Clinical Trial N/A
Not yet recruiting NCT05493943 - P.E.M.F. Therapy of Chronic Wounds N/A
Completed NCT01881815 - Swab Sample Collection for the Detection of Bacterial Proteases N/A
Not yet recruiting NCT06424561 - The Influence of Systematic Psychological Intervention on Patients About VSD Drainage Surgery N/A
Completed NCT05764226 - Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds N/A
Completed NCT03678636 - WOUNDCHEK Bacterial Status Benefits Evaluation N/A
Terminated NCT03198169 - A Study to Investigate Two Atteris Antimicrobial Products on Chronic Wound Healing. N/A
Withdrawn NCT04172363 - Clinical Relevance of the Antimicrobial Resistance Testing in the Treatment of Chronic Wounds With Antiseptics Phase 3
Not yet recruiting NCT05187676 - Clinical Evaluation of an Innovative Non-contact Optical Device for Skin Oxygenation Imaging N/A
Recruiting NCT00535548 - Hematopoietic Stem Cell Therapy in Chronic Wounds Using a Pressure Sore Model Phase 1